ArticleActa pharmaceutica Sinica. B2026

Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma.

Deby Fajar Mardhian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.